A Single-Blind, Randomized, Parallel Arm, Phase II Proof-of-Concept Study of the Safety and Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Transplantation in Cervical Spinal Cord Injury

Trial Profile

A Single-Blind, Randomized, Parallel Arm, Phase II Proof-of-Concept Study of the Safety and Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Transplantation in Cervical Spinal Cord Injury

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Adult neural stem cells (Primary)
  • Indications Spinal cord injuries
  • Focus Proof of concept; Therapeutic Use
  • Acronyms Pathway
  • Sponsors StemCells
  • Most Recent Events

    • 31 May 2016 According to a StemCells Inc. media release, the Interim Analysis Data Monitoring Committee concluded that the data failed the futility criteria established for the interim analysis and recommended cessation of the study.
    • 31 May 2016 According to a StemCells, Inc. media release, status changed from recruiting to discontinued.
    • 18 Apr 2016 According to a StemCells media release, enrollment of cohort I has been complete and the company is now enrolling patients into cohort II. 19 patients have been enrolled and randomised and the enrollment is expected to be completed by the end of September 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top